Christopher Peetz is CEO at Mirum Pharmaceuticals, Inc. (MIRM). They have made 17 open-market trades across 2 companies since 2019, most recently 2026-09-01.
CIK 0001614740
4 open-market purchases totalling $422K since 2019, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MIRM | 194,440 | $15.6M |
| ARQT | 4,315 | $124K |
| ALPN | 1,900 | $123K |
| Total | $15.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRM | SELL · 10b5-1 | 2026-09-01 | 2026-09-03 | $98.68 | $3.0M | -2.9% | -18.9% | — |
| MIRM | SELL · 10b5-1 | 2026-08-10 | 2026-08-11 | $98.92 | $2.0M | -3.3% | +1.0% | — |
| MIRM | SELL · 10b5-1 | 2026-07-06 | 2026-07-08 | $122.27 | $2.4M | -9.5% | -22.0% | -38.5% |
| MIRM | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $95.84 | $2.9M | +7.5% | +35.8% | +5.9% |
| MIRM | SELL | 2026-03-16 | 2026-03-17 | $91.98 | $7.5M | -7.1% | +0.7% | +6.2% |
| MIRM | SELL | 2026-02-02 | 2026-02-03 | $103.30 | $941K | -2.5% | -16.9% | -0.0% |
| MIRM | SELL | 2026-01-26 | 2026-01-27 | $96.19 | $657K | -1.0% | -9.2% | -8.9% |
| MIRM | SELL | 2026-01-22 | 2026-01-23 | $93.33 | $662K | +8.1% | +10.1% | -4.4% |
| MIRM | SELL · 10b5-1 | 2025-08-11 | 2025-08-12 | $62.00 | $2.5M | +10.0% | +16.9% | +7.2% |
| MIRM | SELL · 10b5-1 | 2025-08-07 | 2025-08-08 | $55.25 | $2.2M | +10.8% | +28.5% | +12.4% |
| MIRM | SELL | 2025-03-17 | 2025-03-18 | $44.21 | $2.4M | +4.3% | -11.3% | +14.4% |
| MIRM | SELL · 10b5-1 | 2025-03-03 | 2025-03-04 | $46.91 | $3.8M | -2.1% | -4.4% | +1.7% |
| MIRM | SELL | 2025-02-03 | 2025-02-04 | $48.22 | $878K | -0.7% | -13.8% | -12.4% |
| MIRM | SELL | 2025-01-24 | 2025-01-27 | $47.92 | $655K | +5.8% | +4.3% | -14.7% |
| MIRM | SELL | 2025-01-07 | 2025-01-08 | $42.82 | $641K | +12.8% | +23.3% | -5.0% |
| MIRM | SELL | 2024-02-02 | 2024-02-05 | $26.19 | $315K | +10.5% | +8.4% | +0.6% |
| MIRM | SELL | 2024-01-08 | 2024-01-09 | $28.03 | $292K | -3.9% | -1.9% | -5.8% |
| MIRM | SELL | 2023-07-03 | 2023-07-05 | $25.65 | $282K | +5.4% | +2.8% | +15.7% |
| MIRM | SELL | 2023-01-09 | 2024-03-18 | $20.62 | $213K | -5.6% | -10.4% | +24.0% |
| MIRM | BUY | 2021-11-24 | 2021-11-29 | $14.40 | $101K | +5.5% | +16.0% | +74.8% |
| MIRM | SELL | 2021-10-01 | 2021-10-01 | $19.26 | $141K | -12.1% | -15.6% | -18.3% |
| ALPN | SELL · Routine | 2021-09-23 | 2021-09-24 | $10.17 | $19K | +10.0% | +0.5% | +26.3% |
| ALPN | BUY | 2021-09-23 | 2021-09-27 | $10.17 | $19K | +12.3% | +7.0% | +26.4% |
| MIRM | BUY | 2020-12-23 | 2020-12-28 | $18.72 | $150K | +4.1% | -5.2% | +1.1% |
| MIRM | BUY | 2019-09-06 | 2019-09-10 | $10.98 | $152K | -11.0% | -9.2% | -7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.